Principal Financial Group’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-10,417
| Closed | -$5K | – | 2583 |
|
|
2022
Q3 | $5K | Buy |
10,417
+310
| +3% | +$149 | ﹤0.01% | 2491 |
|
|
2022
Q2 | $9K | Sell |
10,107
-70
| -0.7% | -$62 | ﹤0.01% | 2507 |
|
|
2022
Q1 | $56K | Sell |
10,177
-572
| -5% | -$3.15K | ﹤0.01% | 2481 |
|
|
2021
Q4 | $104K | Sell |
10,749
-5,381
| -33% | -$52.1K | ﹤0.01% | 2440 |
|
|
2021
Q3 | $288K | Sell |
16,130
-2,611
| -14% | -$46.6K | ﹤0.01% | 2319 |
|
|
2021
Q2 | $457K | Buy |
+18,741
| New | +$457K | ﹤0.01% | 2238 |
|
|
2020
Q4 | – | Sell |
-16,236
| Closed | -$81K | – | 2474 |
|
|
2020
Q3 | $81K | Sell |
16,236
-804
| -5% | -$4.01K | ﹤0.01% | 2279 |
|
|
2020
Q2 | $102K | Buy |
17,040
+5,413
| +47% | +$32.4K | ﹤0.01% | 2247 |
|
|
2020
Q1 | $52K | Hold |
11,627
| – | – | ﹤0.01% | 2150 |
|
|
2019
Q4 | $110K | Sell |
11,627
-137
| -1% | -$1.3K | ﹤0.01% | 2181 |
|
|
2019
Q3 | $92K | Sell |
11,764
-380
| -3% | -$2.97K | ﹤0.01% | 2186 |
|
|
2019
Q2 | $191K | Buy |
+12,144
| New | +$191K | ﹤0.01% | 2152 |
|